Table 3.
Rank | Topic | % |
1 | Sector Analysis | 11 |
2 | Disease burden | 9 |
3 | Management & organization | 8 |
4 | Accessibility | 7 |
Programme evaluation | 7 | |
Research to evidence | 7 | |
5 | Financing | 6 |
Human resources | 6 | |
6 | Community participation | 4 |
Costing & cost effectiveness | 4 | |
Decentralisation/local health systems | 4 | |
Information, Education and Communication | 4 | |
Insurance | 4 | |
Pharmaceutical policy & management | 4 | |
Quality | 4 | |
7 | Equity | 3 |
Policy process | 3 | |
8 | Economic policy and health | 2 |
Information systems | 2 | |
Rank | Beneficiaries/Issue | % |
1 | Community | 15 |
2 | Equity/poverty | 14 |
3 | Hospital | 12 |
4 | 1st level | 11 |
Gender/women | 11 | |
Rural areas | 11 | |
5 | Children/adolescents | 10 |
6 | Public private mix | 6 |
7 | Urban areas | 5 |
8 | Elderly | 4 |
9 | Indigenous peoples/traditional medicine | 3 |
Rank | Health Problem | % |
1 | Reproductive health | 30 |
2 | HIV-AIDS | 11 |
Nutrition | 11 | |
TB | 11 | |
3 | Chronic | 7 |
Environmental health | 7 | |
Malaria | 7 | |
Mental health | 7 | |
4 | Other infectious | 6 |
5 | Other | 3 |